MMP14 predicts a poor prognosis in patients with colorectal cancer
Authors:
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 83, 36-42
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makersJournal of Cerebral Blood Flow & Metabolism, 2016
- Increased expression of MMP14 correlates with the poor prognosis of Chinese patients with gastric cancerGene, 2015
- Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and RadiotherapyJNCI: Journal of the National Cancer Institute, 2015
- Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLHNature Cell Biology, 2014
- MT1‐MMP: A potent modifier of pericellular microenvironmentJournal of Cellular Physiology, 2005
- An MT1-MMP-PDGF receptor-β axis regulates mural cell investment of the microvasculatureGenes & Development, 2005
- Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMPJournal of Cell Biology, 2004
- Matrix-directed regulation of pericellular proteolysis and tumor progressionSeminars in Cancer Biology, 2002
- Tumour markers of prognosis in colorectal cancerBritish Journal of Cancer, 1998
- A matrix metalloproteinase expressed on the surface of invasive tumour cellsNature, 1994